Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 15763228)

1.

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.

Wilson CL, Jurk D, Fullard N, Banks P, Page A, Luli S, Elsharkawy AM, Gieling RG, Chakraborty JB, Fox C, Richardson C, Callaghan K, Blair GE, Fox N, Lagnado A, Passos JF, Moore AJ, Smith GR, Tiniakos DG, Mann J, Oakley F, Mann DA.

Nat Commun. 2015 Apr 16;6:6818. doi: 10.1038/ncomms7818.

2.

Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?

Sakhuja P.

World J Gastroenterol. 2014 Nov 28;20(44):16474-9. doi: 10.3748/wjg.v20.i44.16474.

3.

Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress.

Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC.

Redox Biol. 2014;3:100-8. doi: 10.1016/j.redox.2014.09.005. Epub 2014 Sep 28.

4.

Non-invasive diagnosis of alcoholic liver disease.

Mueller S, Seitz HK, Rausch V.

World J Gastroenterol. 2014 Oct 28;20(40):14626-41. doi: 10.3748/wjg.v20.i40.14626.

5.

Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Kim W, Kim DJ.

World J Hepatol. 2014 Oct 27;6(10):688-95. doi: 10.4254/wjh.v6.i10.688. Review.

6.

Diagnosis of alcoholic liver disease.

Torruellas C, French SW, Medici V.

World J Gastroenterol. 2014 Sep 7;20(33):11684-99. doi: 10.3748/wjg.v20.i33.11684. Review.

7.

Diagnostic challenges in alcohol use disorder and alcoholic liver disease.

Vonghia L, Michielsen P, Dom G, Francque S.

World J Gastroenterol. 2014 Jul 7;20(25):8024-32. doi: 10.3748/wjg.v20.i25.8024. Review.

8.

Acute liver injury in a patient with alcohol dependence: a case resembling autoimmune hepatitis or drug-induced liver injury.

Hayashi M, Kanda T, Nakamura M, Miyamura T, Yasui S, Nakamoto S, Wu S, Arai M, Imazeki F, Yokosuka O.

Case Rep Gastroenterol. 2014 Apr 5;8(1):129-33. doi: 10.1159/000362442. eCollection 2014 Jan.

9.

Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Neuman MG, Cohen L, Zakhari S, Nanau RM, Mueller S, Schneider M, Parry C, Isip R, Seitz HK.

Alcohol Alcohol. 2014 Jul-Aug;49(4):373-80. doi: 10.1093/alcalc/agu021. Epub 2014 May 9.

10.

Pharmacotherapy of acute alcoholic hepatitis in clinical practice.

Abenavoli L, Milic N, Rouabhia S, Addolorato G.

World J Gastroenterol. 2014 Mar 7;20(9):2159-67. doi: 10.3748/wjg.v20.i9.2159. Review.

11.

Role of mitochondria in alcoholic liver disease.

Nassir F, Ibdah JA.

World J Gastroenterol. 2014 Mar 7;20(9):2136-42. doi: 10.3748/wjg.v20.i9.2136. Review.

12.

KASL clinical practice guidelines: management of alcoholic liver disease.

Korean Association for the Study of the Liver (KASL).

Clin Mol Hepatol. 2013 Sep;19(3):216-54. doi: 10.3350/cmh.2013.19.3.216. Epub 2013 Sep 30. No abstract available.

13.

Hepatoprotective Effect of Fermented Soybean (Nutrient Enriched Soybean Tempeh) against Alcohol-Induced Liver Damage in Mice.

Mohd Yusof H, Ali NM, Yeap SK, Ho WY, Beh BK, Koh SP, Long K, Abdul Aziz S, Alitheen NB.

Evid Based Complement Alternat Med. 2013;2013:274274. doi: 10.1155/2013/274274. Epub 2013 Aug 22.

14.

Alcoholic hepatitis: current challenges and future directions.

Singal AK, Kamath PS, Gores GJ, Shah VH.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):555-64; quiz e31-2. doi: 10.1016/j.cgh.2013.06.013. Epub 2013 Jun 28. Review.

15.

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.

Kamada Y, Akita M, Takeda Y, Yamada S, Fujii H, Sawai Y, Doi Y, Asazawa H, Nakayama K, Mizutani K, Fujii H, Yakushijin T, Miyazaki M, Ezaki H, Hiramatsu N, Yoshida Y, Kiso S, Imai Y, Kawada N, Takehara T, Miyoshi E.

PLoS One. 2013 Jun 21;8(6):e66328. Print 2013.

16.

Lymphocyte subsets in alcoholic liver disease.

Matos LC, Batista P, Monteiro N, Ribeiro J, Cipriano MA, Henriques P, Girão F, Carvalho A.

World J Hepatol. 2013 Feb 27;5(2):46-55. doi: 10.4254/wjh.v5.i2.46.

17.

Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.

Sookoian S, Pirola CJ.

PLoS One. 2013;8(3):e58895. doi: 10.1371/journal.pone.0058895. Epub 2013 Mar 13.

18.

Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.

Støy S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Grønbæk H, Deleuran B, Vilstrup H.

PLoS One. 2013;8(1):e55101. doi: 10.1371/journal.pone.0055101. Epub 2013 Jan 25.

19.

Hepatic fat assessment using advanced Magnetic Resonance Imaging.

Pang Y, Yu B, Zhang X.

Quant Imaging Med Surg. 2012 Sep;2(3):213-8. doi: 10.3978/j.issn.2223-4292.2012.08.05. No abstract available.

20.

Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C.

Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, Mazulli T, Moussa G, Patel A, Baig AA, Cohen L.

Int J Hepatol. 2012;2012:231210. doi: 10.1155/2012/231210. Epub 2012 Feb 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk